drugset / Trial / NCT01947114

Remifentanil Use in Pediatric Rigid Bronchoscopy

NCT01947114 ↗

Phase 4 Completed 40 enrolled Bezmialem Vakif University
RandomizedSingle-blindTreatment

Summary

Purpose: In this study we wanted to compare bolus propofol and ketamine as an adjuvant to remifentanil-based total intravenous anesthesia for pediatric rigid bronchoscopy. Materials and Methods: Forty children under 12 years of age scheduled for rigid bronchoscopy were included. After midazolam premedication, remifentanil infusion 1 µg/kg/min was started and patients were randomly allocated to receive either propofol (Group P) or ketamine (Group K) and mivacurium for muscle relaxation. Anesthesia was maintained with remifentanil infusion 1 µg/kg/min and bolus doses of propofol or ketamine. After rigid bronchoscopy remifentanil 0.05 µg/kg/min was maintained until extubation. Hemodynamic parameters, emergence characteristics and adverse events were evaluated.

Timeline

Start
2005-11
Primary completion
2006-08
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 0.25 mg/kg —
Comparator Ketamine Small molecule 0.5 mg/kg —
Comparator Ketamine Small molecule 2 mg/kg —
Comparator Ketamine Small molecule 3 mg/kg —
Comparator Propofol Small molecule 0.5 mg/kg —
Comparator Propofol Small molecule 1 mg/kg —
Comparator Propofol Small molecule 2 mg/kg —
Comparator Propofol Small molecule 4 mg/kg —
Comparator Remifentanil Small molecule 0.05 ug/kg —
Comparator Remifentanil Small molecule 1 ug/kg —

Indications